GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Allarity Therapeutics Inc (FRA:C6D0) » Definitions » FCF Yield %

Allarity Therapeutics (FRA:C6D0) FCF Yield % : -137.91 (As of Jun. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Allarity Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Allarity Therapeutics's Trailing 12-Month Free Cash Flow is €-10.24 Mil, and Market Cap is €7.45 Mil. Therefore, Allarity Therapeutics's FCF Yield % for today is -137.91%.

The historical rank and industry rank for Allarity Therapeutics's FCF Yield % or its related term are showing as below:

FRA:C6D0' s FCF Yield % Range Over the Past 10 Years
Min: -1288.68   Med: 0   Max: 0
Current: -137.91


FRA:C6D0's FCF Yield % is ranked worse than
88.13% of 1550 companies
in the Biotechnology industry
Industry Median: -14.605 vs FRA:C6D0: -137.91

Allarity Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


Allarity Therapeutics FCF Yield % Historical Data

The historical data trend for Allarity Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allarity Therapeutics FCF Yield % Chart

Allarity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
- - -0.59 -12.31 -2.87

Allarity Therapeutics Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -584.30 -26.46 -6.96 -1.51 -1.15

Competitive Comparison of Allarity Therapeutics's FCF Yield %

For the Biotechnology subindustry, Allarity Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allarity Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Allarity Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Allarity Therapeutics's FCF Yield % falls into.



Allarity Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Allarity Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-11.687 / 407.097824
=-2.87%

Allarity Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.368 * 4 / 474.0646208
=-1.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allarity Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Allarity Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Allarity Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Allarity Therapeutics (FRA:C6D0) Business Description

Traded in Other Exchanges
Address
24 School Street, 2nd Floor, Boston, MA, USA
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

Allarity Therapeutics (FRA:C6D0) Headlines

No Headlines